Acadia Pharmaceuticals Inc (ACAD)
SBC to Revenue
10.27%
Quarterly · Period ending:
ACAD SBC to Revenue
Latest reported10.27%period ending
Latest reported10.27%period ending
ACAD Quarterly SBC/Revenue (0.00% → 10.27%)
Latest values, visible window
High-resolution chart · PNG
ACAD sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 10.2734% | |
| 5.4831% | |
| 0% | |
| 4.7302% | |
| 5.4202% | |
| 4.6579% | |
| 4.0254% | |
| 10.4488% | |
| 6.4824% | |
| 7.1661% | |
| 7.8008% | |
| 8.7572% | |
| 9.1712% | |
| 12.4133% | |
| 10.5605% | |
| 14.0092% | |
| 15.2434% | |
| 12.9586% | |
| 9.8503% | |
| 11.812% | |
| 19.0981% | |
| 12.3731% | |
| 17.5155% | |
| 17.7248% | |
| 17.717% | |
| 24.8124% | |
| 20.0995% | |
| 23.4675% | |
| 24.5442% | |
| 31.5809% | |
| 34.2465% | |
| 34.5922% | |
| 36.0163% | |
| 41.8311% | |
| 50.5463% | |
| 55.3657% | |
| 59.8655% | |
| 101.8645% | |
| 128.8915% | |
| 265.9263% | |
| 14,312.3711% | |
| 298,875% | |
| 52,364.7059% | |
| 23,756.4103% | |
| 749,900% | |
| 363,200% | |
| 9,882.9787% | |
| 26,006.6667% | |
| 15,467.8571% | |
| 10,540% | |
| 5,875.6757% | |
| 787.9167% | |
| 235.9202% | |
| 139.5683% | |
| 145% | |
| 14.0311% | |
| 79.7997% | |
| 91.7778% | |
| 69.3878% | |
| 68.6644% | |
| 90% | |
| 86.2069% | |
| 0.949% | |
| 17.0795% | |
| 16.2386% | |
| 22.5504% | |
| 18.7677% | |
| 25.0924% | |
| 33.8462% | |
| 153.7433% | |
| 919.0769% | |
| 0% | |
| 0% | |
| 103.7221% | |
| 271.3203% | |
| 0% | |
| 0% | |
| 65% | |
| 190.5245% | |
| 0% | |
| 0% | |
| 35,474.9704% | |
| 53,528.4486% | |
| 0% | |
| 0% | |
| 15,964.2181% | |
| 217,445.0803% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |